1-201361314-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM1BS2
The NM_001276345.2(TNNT2):c.775G>A(p.Asp259Asn) variant causes a missense change. The variant allele was found at a frequency of 0.00000991 in 1,614,080 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D259V) has been classified as Uncertain significance.
Frequency
Consequence
NM_001276345.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152100Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251474Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135910
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461862Hom.: 0 Cov.: 31 AF XY: 0.00000963 AC XY: 7AN XY: 727240
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152218Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74434
ClinVar
Submissions by phenotype
not provided Uncertain:4
- -
- -
Identified as a variant of uncertain significance in cohorts of individuals with arrhythmia and cardiomyopathy in the literature; however, specific information was not provided about the number of individuals with the variant, their phenotype, or presence/absence of other variants (PMID: 23861362; 30847666; 30165862); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30847666, 30165862, 23861362) -
The TNNT2 c.745G>A; p.Asp249Asn variant (rs141805127) is reported in the literature in one individual with noncompaction cardiomyopathy, one individual from a cardiomyopathy cohort, and as a secondary variant from an exome cohort (Lu 2018, Ng 2013, van Lint 2019). This variant is also reported in ClinVar (Variation ID: 181630). This variant is found in the Admixed American population with an allele frequency of 0.01% (5/35426 alleles) in the Genome Aggregation Database. Computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.658). Due to limited information, the clinical significance of this variant is uncertain at this time. References: Lu C et al. Molecular analysis of inherited cardiomyopathy using next generation semiconductor sequencing technologies. J Transl Med. 2018 Aug 30;16(1):241. PMID: 30165862. Ng D et al. Interpreting secondary cardiac disease variants in an exome cohort. Circ Cardiovasc Genet. 2013 Aug;6(4):337-46. PMID: 23861362. van Lint FHM et al. Large next-generation sequencing gene panels in genetic heart disease: yield of pathogenic variants and variants of unknown significance. Neth Heart J. 2019 Jun;27(6):304-309. PMID: 30847666. -
Dilated cardiomyopathy 1D Uncertain:2
- -
ACMG Criteria: PM2_P, PP3; Variant was found in heterozygous state -
Cardiomyopathy Uncertain:2
- -
This missense variant replaces aspartic acid with asparagine at codon 249 of the TNNT2 protein. Computational prediction tools indicate that this variant's impact on protein structure and function is inconclusive. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in one individual affected with noncompaction cardiomyopathy (PMID: 30847666) and in one individual affected with an unspecified cardiomyopathy (PMID: 30165862). This variant has been identified in 6/282830 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Hypertrophic cardiomyopathy 2 Uncertain:2
- -
- -
Dilated cardiomyopathy 1D;C1861864:Hypertrophic cardiomyopathy 2;C2676271:Cardiomyopathy, familial restrictive, 3 Uncertain:2
- -
This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 249 of the TNNT2 protein (p.Asp249Asn). This variant is present in population databases (rs141805127, gnomAD 0.01%). This missense change has been observed in individual(s) with TNNT2-related conditions (PMID: 30165862, 30847666). This variant is also known as p.Asp256Asn. ClinVar contains an entry for this variant (Variation ID: 181630). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt TNNT2 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiomyopathy, familial restrictive, 3 Uncertain:1
- -
Cardiovascular phenotype Uncertain:1
The p.D249N variant (also known as c.745G>A), located in coding exon 13 of the TNNT2 gene, results from a G to A substitution at nucleotide position 745. The aspartic acid at codon 249 is replaced by asparagine, an amino acid with highly similar properties. This variant has been reported in one individual from a cardiomyopathy cohort and as a secondary cardiac variant in an exome cohort; however clinical details were limited (Ng D et al. Circ Cardiovasc Genet, 2013 Aug;6:337-46; Lu C et al. J Transl Med, 2018 08;16:241). This variant has also been reported in a pediatric cardiomyopathy cohort (Ware SM et al. Am J Hum Genet, 2022 Feb;109:282-298). This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at